期刊文献+

老年肺癌患者外周血细胞表面DC分子的表达与生存的关系 被引量:4

Study on the relationship between the expression levels of peripheral blood dendritic cell surface molecule and survival of old patients with lung cancer
下载PDF
导出
摘要 目的从临床角度了解树突状细胞(DC)表面分子在外周血细胞表面的表达与老年肺癌患者生存的关系。方法收集确诊为肺癌的20例老年患者外周血和8例门诊健康查体老年人外周血,用流式细胞仪检测DC表型CD80、CD83、CD86和CD1a,随访1年,将死亡的老年患者和存活的患者分组,门诊健康查体老年人作为对照,进行统计学分析。结果除CD86外,老年死亡组与对照组比较CD80、CD83和CD1a均下降明显,其中CD1a在组间比较P<0.05,CD80、CD83在组间比较P<0.01;老年存活组与死亡组CD83和CD86比较差异有显著性(P<0.05);老年对照组和老年存活组CD1a、CD80、CD83和CD86比较差异无显著性。结论老年肺癌患者的死亡可能与DC细胞表面表型表达下降有关,在健康的和存活的老年人中发现,DC细胞表面表型有高表达,尤其是CD83的表达下降与肺癌患者死亡的关系较为密切。 Objectvie To study the relationship between the expression levels of peripheral blood dendritic eeU(DC) surface molecule and survival of old patients with lung cancer. Method Peripheral blood was eoUeeted from 20 old patients with lung cancer and the expression levels of CD80, CD83, CD86 and CD1a were examined using FCM. The dead and live lung cancer patients were divided into two groups during 1 year of follow up, and 8 healthy old people were used as a control group. Result The expression levels of CD80,CD83 and CD1a on DC surface between dead patients and control group were significantly different except CD86. The expression of CD1a, CD80, CD83 and CD86 between live patients and control group had no difference. Conclusion The dead patients with lung cancer had lower expression levels of CD80, CD83, CD1a and CD86 than live and healthy old people groups. The lower expression levels of CD83 may be associated with death of old patients with lung cancer.
出处 《中国肿瘤临床与康复》 2007年第1期5-7,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 肺肿瘤 树突状细胞 老年 Lung neoplasms Dendritic cell Elderly
  • 相关文献

参考文献9

  • 1Vicari AP,Caux C ,Tfinchiefi G,et al. Tumor escape form immune surveillance through dendritic cell inactivation [ J ]. Semin Cancer Biol,2002, ( 1 ) :12:33-42.
  • 2Gutzmer R, Li W, Sutterwala S, et al. A tumol-associated glycoprotein that blocks MHC class Ⅱ-dependent antigen presentation by dendritic cells[ J]. J Immunol,2004,173 ( 2 ) : 1023-1032.
  • 3Wolff M, Batten, WY, Posovszky C, et al. Gangliosides inhibit the development form monocytes to dendritic cells [ J ]. Clin Exp Immunol,2002,130(3) :441-448.
  • 4Peguet-Navarro J, Sportouch M, Popa 1, et al. Gangliosides form human melanoma tumors impair dendritic cell differentiation form monocytes and induce their apoptosis [ J ]. Immunology,2003,170( 7 ) : 3488-3494.
  • 5Katsenelson SN, Galina VS, Svetlam BS, et al. Human small cell lung carcinoma and carcionoid tumor regulate dendrirtic cell maturation and function[J]. Med Pathol,2001,15 :226-230.
  • 6Gabrilovich D. Mechanisms and functional significancer of tumourinduced dendritic-cell defects [ J ]. Nat Rev Immunol, 2004, 4(12) :941-952.
  • 7Baratelli FE, Heuze-Vourc'h N, Krysan K, et al. Prostaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrix [ J ]. J Immunol,2004,173 (9) :5458-5466.
  • 8Do Y, Mainali E, Nagarkatti PS, et al. Bryostatin-1 in combination with ealeium ionophore promotes the maturation of human umbilical cord-blood monocyte-derived dendritic cells capable of activating neonatal alloreactive T eells[ J]. Cell Immunol,2004,231 (1-2) :8-13.
  • 9Furihata M, Ono Y, lchikawa K, et al. Prognostic significance of CD83 positive,mature dendritic cells in the gallaladder carcinoma[ J ]. Oncol Rep,2005,14 ( 2 ) : 353-356.

同被引文献30

  • 1杨琳,郭明秋,陈立茵.CD137分子对衰老小鼠T细胞活化的影响[J].中国老年学杂志,2005,25(6):685-687. 被引量:5
  • 2史进方,顾国浩,孙中文,张学光.膜型和可溶性CD28分子在衰老过程中的调节性表达[J].中华老年医学杂志,2006,25(4):288-289. 被引量:3
  • 3石云杰,顾国浩,史进方,钱齐宏,孙中文,程钢,孙玮丽,邱玉华.老年人T细胞膜型CD28及血清中可溶性CD28的表达及其意义[J].现代免疫学,2007,27(1):38-40. 被引量:7
  • 4Pawelec, G. Molecular and cell biological studies of ageing and their application to considerations of T lymphocyte immunosenescence [ J ]. Mech Ageing Dev, 1995,79( 1 ) : 1-32.
  • 5Boucher N, Dufeu-Duchesne T, Vicaut E, et al. CD28 expression in T cell aging and human longevity[J]. Exp Gerontol, 1998, 33(3) :267-282.
  • 6Shimada Y, Hayashi M, Nagasaka Y,et al. Age-associated up-regulation of a negative co-stimulatory receptor PD-1 in mouse CD4^+ T cells[ J ]. Exp Gerontol,2009,44 ( 8 ) :517-522.
  • 7Leng Q, Bentwich Z, Borkow G. CTLA4 upregulation during aging [ J]. Mech Ageing Dev, 2002, 123 (10) : 1419-1421.
  • 8Rizvi M, Pathak D, Freedman JE,et al. CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease [J].Trends Mol Med, 2008, 14 (12) : 530-538.
  • 9Inami N, Nomura S, Inami O, et al. Significance of soluble CD40 ligand, adiponectin and reactive oxygen metabolites in aging[J]. Arch Gerontol Geriatr,2009,49 ( 1 ) : 13-16.
  • 10Myers LM, Vella AT. Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation [ J ]. Trends Immunol, 2005, 26(8) : 440-446.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部